InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

LeonaBio, Inc.

LONA Clue Score29
United States Fiscal year ends December CIK 0001620463 Results filed 14 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

81
Insider
Date
Role
Action
Shares
Price
Amount
Perceptive Advisors LLC
26 Oct 2026
Director
Exercised, kept indirect
776,648
$0.00
$776.65
David J. Portman
26 Oct 2026
10% owner
Buy indirect
3,149,470
$3,149.47
left out
Martin Javier San
4 Mar 2026
Chief Medical Officer
Sell
1,720
$5.37
$9.24K
Kevin Church
4 Mar 2026
Chief Scientific Officer
Sell
1,359
$5.37
$7.30K
Mark Worthington
4 Mar 2026
GENERAL COUNSEL and CCO
Sell
1,328
$5.37
$7.13K
Robert Renninger
4 Mar 2026
Chief Financial Officer
Sell
906
$5.37
$4.87K
Mark James Litton
4 Mar 2026
PRESIDENT and CEO
Sell
5,156
$5.37
$27.69K
Mark Worthington
2 Jan 2026
General Counsel and CCO
Sell
876
$6.88
$6.03K
Kevin Church
2 Jan 2026
Chief Scientific Officer
Sell
876
$6.88
$6.03K
Robert Renninger
2 Jan 2026
Chief Financial Officer
Sell
297
$6.88
$2.04K
Mark James Litton
2 Jan 2026
President and CEO
Sell
2,586
$6.88
$17.79K
Martin Javier San
2 Jan 2026
Chief Medical Officer
Sell
1,644
$6.88
$11.31K
Robert Renninger
1 Jul 2025
SVP, Finance and Accounting
Sell
2,897
$0.29
$850.27
Mark Worthington
1 Jul 2025
General Counsel and CCO
Sell
8,526
$0.29
$2.50K
Martin Javier San
1 Jul 2025
Chief Medical Officer
Sell
10,842
$0.29
$3.18K
Mark James Litton
1 Jul 2025
President and CEO
Sell
25,123
$0.29
$7.37K
Kevin Church
1 Jul 2025
Chief Scientific Officer
Sell
8,526
$0.29
$2.50K
Mark Worthington
2 Jan 2025
General Counsel and CCO
Sell
8,510
$0.56
$4.78K
Robert Renninger
2 Jan 2025
VP of Finance
Sell
2,881
$0.56
$1.62K
Kevin Church
2 Jan 2025
Chief Scientific Officer
Sell
8,510
$0.56
$4.78K
Mark James Litton
2 Jan 2025
President and CEO
Sell
25,107
$0.56
$14.11K
Martin Javier San
2 Jan 2025
Chief Medical Officer
Sell
10,826
$0.56
$6.08K
Mark James Litton
5 Sep 2024
President and CEO
Sell
5,032
$0.57
$2.85K
Mark Worthington
5 Sep 2024
General Counsel
Sell
2,525
$0.57
$1.43K
Kevin Church
5 Sep 2024
Chief Scientific Officer
Sell
2,525
$0.57
$1.43K
Rachel Lenington
5 Sep 2024
COO and CDO
Sell
2,525
$0.57
$1.43K
Andrew Gengos
5 Sep 2024
CFO and Chief Business Officer
Sell
1,272
$0.57
$719.95
Kelly A Romano
24 Jun 2024
Director
Buy
27,400
$2.42
$66.18K
Kelly A Romano
21 Jun 2024
Director
Buy
15,000
$2.26
$33.87K
Rachel Lenington
5 Jan 2024
Chief Operating Officer
Sell
2,412
$2.91
$7.02K
Mark Worthington
5 Jan 2024
General Counsel
Sell
2,412
$2.91
$7.02K
Mark James Litton
5 Jan 2024
Chief Executive Officer
Sell
4,820
$2.91
$14.03K
Perceptive Advisors LLC
29 Dec 2023
Director
Buy indirect
163,954
$2.38
$390.21K
Perceptive Advisors LLC
28 Dec 2023
Director
Buy indirect
409,598
$2.44
$999.42K
Perceptive Advisors LLC
27 Dec 2023
Director
Buy indirect
32,134
$2.28
$73.27K
Andrew Gengos
7 Jun 2023
See Below
Buy
11,719
$3.44
$40.31K
Andrew Gengos
7 Jun 2023
See Below
Buy
2,859
$3.40
$9.72K
Andrew Gengos
7 Jun 2023
See Below
Buy
422
$3.36
$1.42K
Andrew Gengos
5 Jun 2023
See Below
Buy
10,000
$3.02
$30.15K
Andrew Gengos
5 Jun 2023
See Below
Buy
10,000
$3.00
$30.00K
Andrew Gengos
5 Jun 2023
See Below
Buy
10,000
$3.00
$30.00K
Andrew Gengos
5 Jun 2023
See Below
Buy
15,000
$3.00
$45.00K
Hans Moebius
2 Jun 2023
Chief Medical Officer
Exercised, kept
7,882
$1.35
$10.64K
Andrew Gengos
2 Jun 2023
See Below
Buy
3,418
$2.95
$10.07K
Andrew Gengos
2 Jun 2023
See Below
Buy
6,582
$2.86
$18.82K
Andrew Gengos
2 Jun 2023
See Below
Buy
10,012
$2.75
$27.53K
Grant Pickering
30 Mar 2023
Director
Buy
15,000
$2.47
$37.05K
James A Johnson
29 Mar 2023
Director
Buy
5,000
$2.40
$12.00K
Grant Pickering
29 Mar 2023
Director
Buy
10,000
$2.33
$23.30K
Kevin Church
24 Mar 2023
Chief Scientific Officer
Exercised, kept
6,410
$1.35
$8.65K
Kevin Church
5 Jan 2023
Chief Scientific Officer
Sell
2,412
$2.91
$7.02K
Andrew Gengos
5 Jan 2023
See Below
Sell
1,208
$2.91
$3.52K
Glenna Mileson
28 Dec 2022
Chief Financial Officer
Buy
50,000
$2.85
$142.25K
Kelly A Romano
2 Dec 2022
Director
Buy
30,000
$3.29
$98.70K
Hans Moebius
15 Nov 2022
Chief Medical Officer
Buy
5,000
$3.29
$16.44K
Kevin Church
28 Oct 2022
Executive VP, Research
Exercised, kept
3,700
$1.35
$5.00K
Hans Moebius
13 Oct 2022
Chief Medical Officer
Exercised, kept
7,881
$1.35
$10.64K
Perceptive Advisors LLC
30 Jun 2022
Director
Buy indirect
1,101,362
$2.99
$3.29M
Perceptive Advisors LLC
29 Jun 2022
Director
Buy indirect
270,000
$2.99
$807.30K
Hans Moebius
28 Jun 2022
Chief Medical Officer
Buy
10,000
$2.88
$28.80K
Kevin Church
23 Jun 2022
Executive VP, Research
Sell
2,614
$2.69
$7.03K
Rachel Lenington
23 Jun 2022
Chief Operating Officer
Sell
4,193
$2.69
$11.28K
Mark James Litton
23 Jun 2022
Chief Executive Officer
Sell
7,960
$2.69
$21.41K
Glenna Mileson
23 Jun 2022
Chief Financial Officer
Sell
2,614
$2.69
$7.03K
Mark Worthington
23 Jun 2022
General Counsel
Sell
2,614
$2.69
$7.03K
Kevin Church
8 Jun 2022
Executive VP, Research
Exercised, kept
2,500
$1.35
$3.38K
Glenna Mileson
11 Apr 2022
Chief Financial Officer
Exercised, kept
3,000
$10.64
$31.92K
Kelly A Romano
31 Mar 2022
Director
Buy
8,000
$13.11
$104.88K
Kevin Church
18 Feb 2022
Executive VP, Research
Exercised, kept
3,152
$1.19
$3.75K
Glenna Mileson
4 Jan 2022
Chief Financial Officer
Exercised, kept
6,305
$1.35
$8.51K
Mark James Litton
17 Aug 2021
Chief Operating Officer
Exercised, kept
50,440
$1.35
$68.09K
Hans Moebius
21 Jul 2021
Chief Medical Officer
Exercised, kept
15,762
$1.35
$21.28K
Hans Moebius
21 Jul 2021
Chief Medical Officer
Exercised, kept
12,610
$1.35
$17.02K
Glenna Mileson
10 Jun 2021
Chief Financial Officer
Exercised, kept
6,305
$1.35
$8.51K
Kevin Church
8 Jun 2021
Vice President of Discovery
Exercised, kept
3,152
$1.04
$3.28K
John M Fluke Jr
3 Feb 2021
Director
Exercised, kept
3,783
$1.35
$5.11K
John M Fluke Jr
3 Feb 2021
Director
Exercised, kept
25,220
$1.19
$30.01K
Perceptive Advisors LLC
25 Jan 2021
Director
Buy indirect
311,111
$22.50
$7.00M
Joseph Edelman
22 Sep 2020
Director
Buy indirect
1,058,824
$17.00
$18.00M
Perceptive Advisors LLC
22 Sep 2020
10% owner
Buy indirect
1,058,824
$17.00
$18.00M
Rtw Investments, LP
18 Sep 2020
10% owner
Buy indirect
750,000
$17.00
$12.75M

What was left out

Form 4 filings counted 177
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 35
Transactions with no price 1
Shares from compensation/vesting 8,028,100
Sales filed before the plan box existed 5
History held since 22 Sep 2020